AVE 33.3% 0.2¢ avecho biotechnology limited

oxymorphone patch m eets phase 1 end points, page-25

  1. 5,322 Posts.
    Mak. It's a great Ann for investors . However we clearly have index overhang which needs to wash through. I'd reckon the big Ann to rerate POH will be success on multi dose which could generate an early Pain Deal .
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(33.3%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.2¢ 0.3¢ 0.2¢ $16.54K 5.758M

Buyers (Bids)

No. Vol. Price($)
59 96791453 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 58594028 16
View Market Depth
Last trade - 16.10pm 02/08/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.